Searched for
EBITDA POSITIVE
Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...- Tata Consumer crosses Rs 20,000 crore revenue mark in FY26, net profit up 20%Tata Consumer Products achieved a significant milestone, crossing ₹20,000 crore in revenue for FY26. The company reported a 15% revenue inc...
- Meesho: Why Jefferies believes the stock could rally 34% from current levelsJefferies sees significant growth for Meesho. The brokerage initiated coverage with a 'Buy' rating and a target price of Rs 225. This sugge...
- Zepto overtakes Instamart in order count, trails Blinkit in scale and profitabilityFor the January-March quarter of FY26, Blinkit reported a net order value of Rs 14,386 crore, compared with Zepto’s calculated net order va...
- Adani Energy buys IntelliSmart in Rs 3,050-cr deal, becomes India's largest smart metering platformAdani Energy Solutions Ltd (AESL) has acquired IntelliSmart Infrastructure Pvt Ltd for Rs 3,050 crore, significantly expanding its smart me...
- Buy, Sell or Hold: Elara Capital initiates buy on Bharti Airtel; Goldman Sachs has buy rating on IndigoBrokerages remained positive on select telecom, aviation and banking largecaps despite near-term macro uncertainties. Elara Capital initiat...
- Adani Energy Solutions vs Power Grid Corp: Which stock is Jefferies betting on?Jefferies remains bullish on both Adani Energy Solutions and Power Grid Corp but sees significantly stronger growth in AESL, driven by tran...
- HFCL shares slip 10% in two sessions after sharp 165% rally in 2026HFCL shares have corrected about 10% in two sessions after a sharp 165% rally in 2026, driven largely by profit booking. Despite strong fun...
- Tata Motors CV bets on exports, clean mobility for FY27 growthThe company said industry growth is expected to continue in FY27, albeit at a slower pace than the previous year, amid commodity cost press...
- Macquarie initiates 'Underperform' rating on Meesho, sees 25% downside. Here's whyMacquarie has initiated coverage on Meesho with an ‘Underperform’ rating and a target price of Rs 125, implying nearly 25% downside. The br...
- Bullish on autos? Siddhartha Khemka picks Maruti Suzuki and Samvardhana MothersonIndia’s auto sector started FY27 on a mixed note, with passenger vehicles and tractors showing resilience while two-wheelers and commercial...
- AI, data centre boom powers these 9 stocks up to 477% in 2026. Can you still join the party?India's data centre industry is experiencing a multi-year growth phase, fueled by digitalization, cloud adoption, and AI demand. This surge...
- PhysicsWallah dials down schools push after investor uneasePhysicsWallah is shifting its K-12 expansion strategy to an asset-light, online-led model, moving away from capital-intensive school operat...
- Skyroot Aerospace forecasts Rs 977 crore in revenues by FY27, ahead of Vikram-1 launchIndian space startup Skyroot Aerospace projects significant revenue growth, aiming for over Rs 13,000 crore by FY32, driven by launch servi...
- Adani Group cos post record $16 bn capex, all-time high EBITDA of Rs 94,834 cr in FY26Adani Group companies achieved a record capital expenditure of Rs 1.53 lakh crore and an all-time high EBITDA of Rs 94,834 crore in FY26, f...
- Nifty at 25,900 by March 2027? Nomura cites key catalysts to watch out forIndian stocks have seen a sharp fall. Nomura predicts the Nifty will climb almost 11% to reach 25,900 by March 2027. This optimism stems fr...
- OMCs stare at big losses despite recent price hikesOil Marketing Companies are facing substantial losses on petrol and diesel. Despite recent price increases, these companies are still losin...
- Eternal's District ramps up sports push, eyes acquisitionsEternal's District platform is expanding into India's booming sports market, moving beyond ticketing to venue bookings and brand partnershi...
- GP Petroleums Q4 profit rises 8%GP Petroleums reported an 8% year-on-year profit increase in the fourth quarter, driven by improved operating margins despite a revenue dec...
- Tata 1mg turns Ebitda positive across core units as diagnostics crosses Rs 600 crore in ARRThe company said its diagnostics business crossed an annualised revenue run rate of more than Rs 600 crore during the year, growing over 40...
Load More
